2,193
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Ultrasound-guided percutaneous microwave ablation of hepatocellular carcinoma in challenging locations: oncologic outcomes and advanced assistive technology

ORCID Icon, , , , , , , & show all
Pages 89-100 | Received 18 May 2019, Accepted 20 Dec 2019, Published online: 22 Jan 2020

References

  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
  • Oliveri RS, Wetterslev J, Gluud C. Hepatocellular carcinoma. Lancet. 2012; 380:470.
  • Bruix J, Reig M, Sherman M. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology. 2016;150:835–853.
  • Waghray A, Murali AR, Menon KN. Hepatocellular carcinoma: from diagnosis to treatment. World J Hepatol. 2015;7:1020–1029.
  • Benson AB, D’Angelica MI, Abbott DE, et al. Guidelines insights: hepatobiliary cancers, version 2.2019. J Natl Compr Canc Netw. 2019;117:302–310.
  • Liang P, Wang Y. Microwave ablation of hepatocellular carcinoma. Oncology. 2007;72:124–131.
  • Liu X, Wang Z, Chen Z, et al. Efficacy and safety of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion in hepatocellular carcinoma: a systematic review and meta-analysis. Oncol Res. 2017;26:231–239. 
  • Liang P, Yu J, Yu XL, et al. Percutaneous cooled-tip microwave ablation under ultrasound guidance for primary liver cancer: a multicentre analysis of 1363 treatment-naive lesions in 1007 patients in China. Gut. 2012;61:1100–1101.
  • Liang P, Yu J, Lu MD, et al. Practice guidelines for ultrasound-guided percutaneous microwave ablation for hepatic malignancy. World J Gastroenterol. 2013;19:5430–5438.
  • Martin RC, Scoggins CR, McMasters KM. Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience. Ann Surg Oncol. 2010;17:171–178.
  • Wang X, Sofocleous CT, Erinjeri JP, et al. Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases. Cardiovasc Intervent Radiol. 2013;36:166–175.
  • Solbiati M, Muglia R, Goldberg SN, et al. A novel software platform for volumetric assessment of ablation completeness. Int J Hyperthermia. 2019;36:337–343.
  • Kaye EA, Cornelis FH, Petre EN, et al. Volumetric 3D assessment of ablation zones after thermal ablation of colorectal liver metastases to improve prediction of local tumor progression. Eur Radiol. 2019;29:2698–2705.
  • Kim JS, Kim W, So YH, et al. Topographical impact of hepatitis B-related hepatocellular carcinoma on local recurrence after radiofrequency ablation. J Clin Gastroenterol. 2014;48:66–72.
  • Li X, Yu J, Liang P, et al. Ultrasound-guided percutaneous microwave ablation assisted by three-dimensional visualization operative treatment planning system and percutaneous transhepatic cholangial drainage with intraductal chilled saline perfusion for larger hepatic hilum hepatocellular (D ≥ 3 cm): preliminary results. Oncotarget. 2017;8:79742–79749.
  • Zhang D, Liang W, Zhang M, et al. Multiple antenna placement in microwave ablation assisted by a three-dimensional fusion image navigation system for hepatocellular carcinoma. Int J Hyperthermia. 2018;35:122–132.
  • Cheng Z, Yu X, Han Z, et al. Ultrasound-guided hydrodissection for assisting percutaneous microwave ablation of renal cell carcinomas adjacent to intestinal tracts: a preliminary clinical study. Int J Hyperthermia. 2018;34:315–320.
  • Zhi-Yu H, Ping L, Xiao-Ling Y, et al. A clinical study of thermal monitoring techniques of ultrasound-guided microwave ablation for hepatocellular carcinoma in high-risk locations. Sci Rep. 2017;7:41246.
  • Liu F, Liang P, Yu X, et al. A three-dimensional visualisation preoperative treatment planning system in microwave ablation for liver cancer: a preliminary clinical application. Int J Hyperthermia. 2013;29:671–677.
  • Sherman M, Bruix J, Porayko M, et al. Screening for hepatocellular carcinoma: the rationale for the American Association for the Study of Liver Diseases recommendations. Hepatology. 2012;56:793–796.
  • Liang P, Dong B, Yu X, et al. Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology. 2005;235:299–307.
  • Liu F, Liang P, Yu X, et al. A three-dimensional visualisation preoperative treatment planning system in microwave ablation for liver cancer: a preliminary clinical application. Int J Hyperthermia. 2013;29:671–677.
  • An C, Li X, Liang P, et al. A tumor map generated from three-dimensional visualization of image fusion for the assessment of microwave ablation of hepatocellular carcinoma: a preliminary study. Cancer Manag Res. 2019;11:1569–1578.
  • Ahmed M. Image-guided tumor ablation: standardization of terminology and reporting criteria – a 10-year update: supplement to the consensus document. J Vasc Interv Radiol. 2014;25:1706–1708.
  • Fang C, Cortis K, Yusuf GT, et al. Complications from percutaneous microwave ablation of liver tumours: - a pictorial review. Br J Radiol. 2019;92:20180864.
  • Heerink WJ, Solouki AM, Vliegenthart R, et al. The relationship between applied energy and ablation zone volume in patients with hepatocellular carcinoma and colorectal liver metastasis. Eur Radiol. 2018;28:3228–3236.
  • Yu J, Yu XL, Han ZY, et al. Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial. Gut. 2017;66:1172–1173.
  • Yu J, Liang P, Yu X, et al. A comparison of microwave ablation and bipolar radiofrequency ablation both with an internally cooled probe: results in ex vivo and in vivo porcine livers. Eur J Radiol. 2011; 79:124–130.
  • Shady W, Petre EN, Do KG, et al. Percutaneous microwave versus radiofrequency ablation of colorectal liver metastases: ablation with clear margins (A0) provides the best local tumor control. J Vasc Interv Radiol. 2018;29:268–275.e1.
  • Jiao D, Qian L, Zhang Y, et al. Microwave ablation treatment of liver cancer with 2,450-MHz cooled-shaft antenna: an experimental and clinical study. J Cancer Res Clin Oncol. 2010;136:1507–1516.
  • Filippiadis DK, Spiliopoulos S, Konstantos C, et al. Computed tomography-guided percutaneous microwave ablation of hepatocellular carcinoma in challenging locations: safety and efficacy of high-power microwave platforms. Int J Hyperthermia. 2018;34:863–869.
  • Chen J, Peng K, Hu D, et al. Tumor location influences oncologic outcomes of hepatocellular Carcinoma patients undergoing radiofrequency ablation. Cancers (Basel). 2018;10:378.
  • Wang CC, Kao JH. Artificial ascites is feasible and effective for difficult-to-ablate hepatocellular carcinoma. Hepatol Int. 2015;9:514–519.
  • Wu CC, Chen WS, Ho MC, et al. Minimizing abdominal wall damage during high-intensity focused ultrasound ablation by inducing artificial ascites. J Acoust Soc Am. 2008;124:674–679.
  • Seitel A, Engel M, Sommer CM, et al. Computer-assisted trajectory planning for percutaneous needle insertions. Med Phys. 2011;38:3246–3259.
  • Fang CH, Tao HS, Yang J, et al. Impact of three-dimensional reconstruction technique in the operation planning of centrally located hepatocellular carcinoma. J Am Coll Surg. 2015;220:28–37.
  • Zhang J, Qiao QL, Guo XC, et al. Application of three-dimensional visualization technique in preoperative planning of progressive hilar cholangiocarcinoma. Am J Transl Res. 2018;10:1730–1735.